[1]
Hasan, E.K. et al. 2024. Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib or Nilotinib in Iraqi Patients with Chronic Myeloid Leukemia: An Observational Study. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 6, 1 (Mar. 2024), 215–221. DOI:https://doi.org/10.54133/ajms.v6i1.608.